These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4762432)

  • 1. Fractionation studies on plasma of normals and patients with Laron dwarfism and hypopituitary gigantism.
    Bala RM; Beck JC
    Can J Physiol Pharmacol; 1973 Nov; 51(11):845-32. PubMed ID: 4762432
    [No Abstract]   [Full Text] [Related]  

  • 2. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone assay in acromegaly, gigantism, dwarfism and hypopituitarism.
    Daughaday WH
    Postgrad Med; 1969 Nov; 46(5):84-91. PubMed ID: 5361738
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal growth hormone and dwarfism.
    Abucham-Filho JZ; Czepielewski MA; Ribeiro SR; Jaber HE; Lengyel AM; Chacra AR; Vieira JG
    N Engl J Med; 1985 Jul; 313(4):268-9. PubMed ID: 4040212
    [No Abstract]   [Full Text] [Related]  

  • 5. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
    Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
    N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
    Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transferrin, somatomedins and growth].
    Donnadieu M; Schimpff RM; Garnier P; Martinez MJ; Chaussain JL; Job JC
    C R Seances Soc Biol Fil; 1980; 174(4):564-73. PubMed ID: 6449240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].
    Isidori A; Cianfriglia F; Dondero F
    Folia Endocrinol; 1974 Apr; 27(2):179-84. PubMed ID: 4406489
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparison of radioimmunoassay and radioreceptor assay of serum growth hormone in children with growth disorders (author's transl)].
    Maesaka H; Suwa S
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):164-70. PubMed ID: 6989653
    [No Abstract]   [Full Text] [Related]  

  • 12. [Growth hormone (author's transl)].
    Grodecka B
    Postepy Biochem; 1975; 21(2):213-29. PubMed ID: 1153359
    [No Abstract]   [Full Text] [Related]  

  • 13. Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome?
    Spencer GS; Schabel F; Frisch H
    Arch Dis Child; 1980 Feb; 55(2):151-3. PubMed ID: 7377837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The therapeutic problem in pituitary dwarfism. Personal contribution].
    Conti C; Isidori A
    Folia Endocrinol; 1968 Oct; 21(5):559-76. PubMed ID: 5756726
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatomedin A in human serum, determined by radioreceptor assay.
    Takano K; Hall K; Ritzén M; Iselius L; Sievertsson H
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):449-59. PubMed ID: 947120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatomedin-c in the Beckwith-Wiedemann syndrome.
    Robinow M; Shafer AD
    Arch Dis Child; 1981 Jan; 56(1):77-8. PubMed ID: 7193437
    [No Abstract]   [Full Text] [Related]  

  • 18. Actions of growth hormone, prolactin and thyroxine on serum somatomedin-like activity and growth in hypopituitary dwarf mice.
    Holder AT; Wallis M
    J Endocrinol; 1977 Aug; 74(2):223-9. PubMed ID: 894170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy.
    Winterer J; Chrousos G; Cassorla F; Loriaux DL
    J Pediatr; 1984 Jun; 104(6):908-11. PubMed ID: 6539376
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatomedin peptide distribution and somatomedin-binding protein content in cord plasma: comparison to normal and hypopituitary plasma.
    Borsi L; Rosenfeld RG; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1982 Feb; 54(2):223-8. PubMed ID: 6172441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.